Akums Drugs and Pharmaceuticals Limited (AKUMS) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE09XN01023
Key metrics
- Market Cap
- ₹11,483 Cr
- P/E Ratio
- 39.37
- EPS
- 19.05
- Book Value
- 211.64
- P/B Ratio
- 3.57
- ROE
- 7.66%
- ROCE
- 10.62%
- Debt / Equity
- 0.06
- Net Margin
- 6%
- Revenue Growth
- 4.43%
- Profit Growth
- -24.54%
- Dividend Yield
- 0.13%
- 52W High
- ₹775.00
- 52W Low
- ₹409.30
- Market Cap Band
- mid cap
- Face Value
- 2
Ratios computed from the annual results period ending 2026-03-31.
About Akums Drugs and Pharmaceuticals Limited
Akums Drugs and Pharmaceuticals Limited manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally. The company provides drugs, ayurvedic, nutraceuticals, food and dietary supplements, derma and cosmetics, healthcare and hospital products, over-the-counter (OTC) products, active pharmaceutical ingredients, excipients, and compounds. It also offers branded formulations on various dosage forms, including tablets, hard and soft gelatin capsules, liquid orals, sachets, vials, ampoules, form-fill-seal products, topical preparations, eye drops, dry powder injections, and gummies for therapeutic areas, such as antiinfectives, pain management, gastroenterology, orthopaedics, cardio-diabetic care, critical care, respiratory, and gynaecology. In addition, the company operates as pharmaceutical contract development and manufacturing company. Akums Drugs and Pharmaceuticals Limited was incorporated in 2004 and is based in Delhi, India.
- Headquarters
- Delhi, India
- Employees
- 7,337
- Promoter Holding
- 77.37%
The full Akums Drugs and Pharmaceuticals Limited analysis
Create a free account to open the complete AKUMS deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.